CGIM
ONC

Capital Group Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Capital Group Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
16,840
+152
+0.9% +$44.8K 0.72% 39
2026
Q1 		$4.96M Buy
16,688
+1,978
+13% +$640K 0.85% 36
2025
Q4 		$4.47M Buy
14,710
+330
+2% +$108K 0.73% 41
2025
Q3 		$4.9M Buy
14,380
+136
+1% +$41.3K 0.82% 33
2025
Q2 		$3.45M Sell
14,244
-549
-4% -$135K 0.61% 51
2025
Q1 		$4.03M Sell
14,793
-1,643
-10% -$384K 0.82% 36
2024
Q4 		$3.04M Buy
16,436
+406
+3% +$83K 0.58% 50
2024
Q3 		$3.6M Hold
16,030
– – 0.72% 43
2024
Q2 		$2.29M Hold
16,030
– – 0.49% 62
2024
Q1 		$2.51M Buy
16,030
+2,021
+14% +$325K 0.45% 65
2023
Q4 		$2.53M Sell
14,009
-769
-5% -$139K 0.27% 108
2023
Q3 		$2.66M Hold
14,778
– – 0.17% 107
2023
Q2 		$2.63M Buy
14,778
+82
+0.6% +$18.9K 0.13% 109
2023
Q1 		$3.17M Sell
14,696
-1,958
-12% -$470K 0.17% 105
2022
Q4 		$3.66M Buy
+16,654
New +$3.05M 0.14% 104

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital Group Investment Management's ONC Position: Q2 2026 in Review

Capital Group Investment Management increased its BeOne Medicines Ltd (ONC) stake by 0.91% in Q2 2026, buying an estimated $44.8K and bringing the position to 16,840 shares worth $4.8M. The position accounts for 0.72% of the portfolio, ranked #39.

Capital Group Investment Management first reported a position in ONC in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.96M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital Group Investment Management held 16,840 shares of BeOne Medicines Ltd worth $4.8M as of Q2 2026.
  • Capital Group Investment Management bought 152 BeOne Medicines Ltd shares in Q2 2026, an estimated $44.8K.
  • BeOne Medicines Ltd made up 0.72% of Capital Group Investment Management's portfolio in Q2 2026, its #39 holding.
  • Capital Group Investment Management first reported a position in BeOne Medicines Ltd in Q4 2022 and has held it in 15 quarters since.
  • Capital Group Investment Management's BeOne Medicines Ltd position peaked at $4.96M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.